Dear All,
I would like to encourage those of you who have good relationships with your CML doctors to ask them to contact Prof. Mike Richards regarding the ACD on nilotinib and dasatinib.
There is no doubt that Mike Richards is a very sympathetic and humane man and he might be able to help persuade NICE that they are making a mistake and therefore change the recommendation of this ACD.
It would be very powerful if, rather than patients, the expert CML clinicians, who are no doubt as upset as we are by the prospect of not being able to effectively treat their IM resistant/intolerant patients, were to contact Mike Richards directly and share their concerns from a clinical point of view.
If you would like to help me with this idea, please contact me directly with the name of your doctor so we can be sure that we are asking the right people to help and also not subjecting the same doctors to multiples of the same request.
Sandy